- 1. exa
- [10*18 ( HL7V3.0 )] (UMLS (HL7) C1553024) =Quantitative Concept =UnitOfMeasurePrefixSens;
UnitOfMeasurePrefixInsens | - 12. EXAMINATION NOS
- [ ] (UMLS (ICD9CM) C0260880) =Finding
|
- 2. Exacerbated Insomnia
- (UMLS (NCI) C0852928) =Disease or Syndrome
| - 13. Examination of ears and hearing
- (UMLS (ICD9CM) C0015222) =Finding
|
- 3. Exact
- [The two concepts have identical meaning. ( HL7V3.0 )] (UMLS (HL7) C1552871) =Idea or Concept =MapRelationship;
| - 14. Examination of eyes and vision
- [ ] (UMLS (ICD9CM) C1961134) EYE & VISION EXAMINATION;
=Finding ;
|
- 4. Exaggerated Placental Site
- (UMLS (NCI) C1333482) =Neoplastic Process ;
| - 15. Examination Phobia
- (UMLS (NCI) C0349744) =Mental or Behavioral Dysfunction ;
|
- 5. Exalamide
- (UMLS (NCI) C0046146) =Organic Chemical
| - 16. Examination Under Anesthesia
- [A medical inspection, qualified according to the methods employed, as physical examination, radiologic examination, diagnostic imaging examination, etc., performed under conditions of patient's complete or partial local or general insensibility to pain with or without the loss of consciousness, induced by an anesthetic agent or by non-pharmacological anesthesia technique. ( NCI )] (UMLS (NCI) C0558588) =Health Care Activity
|
- 6. Exam
- [An appraisal or evaluation of a patient's condition by a physician or registered nurse, based on clinical and laboratory data, medical history, and the patient's account of symptoms. ( NCI )] (UMLS (NCI) C0582103) =Health Care Activity ;
| - 17. Examinations of form and structure of eye
- [ ] (UMLS (ICD9CM) C0178076) =Diagnostic Procedure
|
- 7. EXAM EARS & HEARING NEC
- [ ] (UMLS (ICD9CM) C1719699) Other examination of ears and hearing =Diagnostic Procedure
| - 18. Examined
- [Having been subjected to inspection or evaluation. ( NCI )] (UMLS (NCI) C0332128) =Finding
|
- 8. Exam Room
- (UMLS (HL7) C1547117) =Spatial Concept =Patient location type;
| - 19. Exaprolol
- [A lipophilic derivative of the adrenergic blocking agent propranolol with sympatholytic activity. Exaprolol competitively binds to and blocks beta-adrenergic receptors in the heart and vascular smooth muscle, thereby causing negative chronotropic and inotropic effects leading to a reduction in cardiac output. ( NCI )] (UMLS (NCI) C0059928) =Organic Chemical; Pharmacologic Substance
|
- 9. EXAM-CLINCAL TRIAL
- (UMLS (ICD9CM) C0949168) Examination of participant in clinical trial for normal comparison or control in clinical research;
=Health Care Activity | - 20. EXAPROLOL HYDROCHLORIDE
- [The hydrochloride form of exaprolol, a lipophilic derivative of the adrenergic blocking agent propranolol with sympatholytic activity. Exaprolol competitively binds to and blocks beta-adrenergic receptors in the heart and vascular smooth muscle, thereby causing negative chronotropic and inotropic effects leading to a reduction in cardiac output. ( NCI )] (UMLS (NCI) C0952592) =Organic Chemical; Pharmacologic Substance
|
- 10. Exametazime
- (UMLS (NCI) C0175035) =Organic Chemical; Pharmacologic Substance
| - 21. EXATECAN
- (UMLS (NCI) C0965941) =Organic Chemical; Pharmacologic Substance ;
|
- 11. Examination for medicolegal reasons
- [ ] (UMLS (ICD9CM) C0260855) =Finding
| - 22. Exatecan Mesylate
- [An anticancer drug that belongs to the family of drugs called topoisomerase inhibitors. Also called DX-8951f. ( NCI )] (UMLS (NCI) C0935945) =Organic Chemical; Pharmacologic Substance ;
|
home
